SEARCH

SEARCH BY CITATION

References

  • 1
    Xu, D., Jiang, H. R., Kewin, P., Li, Y., Mu, R., Fraser, A. R., Pitman, N. et al., IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc. Natl. Acad. Sci. USA 2008. 105: 1091310918.
  • 2
    Prefontaine, D., Lajoie-Kadoch, S., Foley, S., Audusseau, S., Olivenstein, R., Halayko, A. J., Lemiere, C. et al., Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J. Immunol. 2009. 183: 50945103.
  • 3
    Carriere, V., Roussel, L., Ortega, N., Lacorre, D. A., Americh, L., Aguilar, L., Bouche, G. and Girard, J. P., IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl. Acad. Sci. USA 2007. 104: 282287.
  • 4
    Pushparaj, P. N., Tay, H. K., H'Ng, S. C., Pitman, N., Xu, D., McKenzie, A., Liew, F. Y. and Melendez, A. J., The cytokine interleukin-33 mediates anaphylactic shock. Proc. Natl. Acad. Sci. USA 2009. 106: 97739778.
  • 5
    Mok, M. Y., Huang, F. P., Ip, W. K., Lo, Y., Wong, F. Y., Chan, E. Y., Lam, K. F. and Xu, D., Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus. Rheumatology (Oxford) 2010. 49: 520527.
  • 6
    Moussion, C., Ortega, N. and Girard, J. P., The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel “alarmin”? PLoS One 2008. 3: e3331.
  • 7
    Nishida, A., Andoh, A., Imaeda, H., Inatomi, O., Shiomi, H. and Fujiyama, Y., Expression of interleukin 1-like cytokine interleukin 33 and its receptor complex (ST2L and IL1RAcP) in human pancreatic myofibroblasts. Gut 2009. 59: 531541.
  • 8
    Masamune, A., Watanabe, T., Kikuta, K., Satoh, K., Kanno, A. and Shimosegawa, T., Nuclear expression of interleukin-33 in pancreatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2010. 299:G821G832.
  • 9
    Marvie, P., Lisbonne, M., L'Helgoualc'h, A., Rauch, M., Turlin, B., Preisser, L., Bourd-Boittin, K. et al., Interleukin-33 overexpression is associated with liver fibrosis in mice and humans. J. Cell. Mol. Med. 2010. 14: 17261739.
  • 10
    Nile, C. J., Barksby, E., Jitprasertwong, P., Preshaw, P. M. and Taylor, J. J., Expression and regulation of interleukin-33 in human monocytes. Immunology 2010. 130: 172180.
  • 11
    Kumar, S., Tzimas, M. N., Griswold, D. E. and Young, P. R., Expression of ST2, an interleukin-1 receptor homologue, is induced by proinflammatory stimuli. Biochem. Biophys. Res. Commun. 1997. 235: 474478.
  • 12
    Oshikawa, K., Yanagisawa, K., Tominaga, S. and Sugiyama, Y., ST2 protein induced by inflammatory stimuli can modulate acute lung inflammation. Biochem. Biophys. Res. Commun. 2002. 299: 1824.
  • 13
    Roth, G. A., Zimmermann, M., Lubsczyk, B. A., Pilz, J., Faybik, P., Hetz, H., Hacker, S. et al., Up-regulation of interleukin 33 and soluble ST2 serum levels in liver failure. J. Surg. Res. 2010. 163: e79e83.
  • 14
    Haraldsen, G., Balogh, J., Pollheimer, J., Sponheim, J. and Kuchler, A. M., Interleukin-33 – cytokine of dual function or novel alarmin? Trends Immunol. 2009. 30: 227233.
  • 15
    Lamkanfi, M. and Dixit, V. M., IL-33 raises alarm. Immunity 2009. 31: 57.
  • 16
    Weber, L. W., Boll, M. and Stampfl, A., Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit. Rev. Toxicol. 2003. 33: 105136.
  • 17
    Takeda, K., Hayakawa, Y., Van Kaer, L., Matsuda, H., Yagita, H. and Okumura, K., Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc. Natl. Acad. Sci. USA 2000. 97: 54985503.
  • 18
    Dennert, G. and Aswad, F., The role of NKT cells in animal models of autoimmune hepatitis. Crit. Rev. Immunol. 2006. 26: 453473.
  • 19
    Roth, G. A., Faybik, P., Hetz, H., Hacker, S., Ankersmit, H. J., Bacher, A., Thalhammer, T. and Krenn, C. G., Pro-inflammatory interleukin-18 and caspase-1 serum levels in liver failure are unaffected by MARS treatment. Dig. Liver Dis. 2009. 41: 417423.
  • 20
    Zheng, S. J., Wang, P., Tsabary, G. and Chen, Y. H., Critical roles of TRAIL in hepatic cell death and hepatic inflammation. J. Clin. Invest. 2004. 113: 5864.
  • 21
    Ksontini, R., Colagiovanni, D. B., Josephs, M. D., Edwards, C. K., III, Tannahill, C. L., Solorzano, C. C., Norman, J. et al., Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis. J. Immunol. 1998. 160: 40824089.
  • 22
    Gong, Q., Zhang, H., Li, J. H., Duan, L. H., Zhong, S., Kong, X. L., Zheng, F. et al., High-mobility group box 1 exacerbates concanavalin A-induced hepatic injury in mice. J. Mol. Med. 2010. 88: 12891298.
  • 23
    Zhao, W. and Hu, Z., The enigmatic processing and secretion of interleukin-33. Cell. Mol. Immunol. 2010. 7: 260262.
  • 24
    Oboki, K., Ohno, T., Kajiwara, N., Arae, K., Morita, H., Ishii, A., Nambu, A. et al., IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc. Natl. Acad. Sci. USA 2010. 107: 1858118586.
  • 25
    Swain, M. G., Natural killer T cells within the liver: conductors of the hepatic immune orchestra. Dig. Dis. 2010. 28: 713.
  • 26
    Notas, G., Kisseleva, T. and Brenner, D., NK and NKT cells in liver injury and fibrosis. Clin. Immunol. 2009. 130: 1626.
  • 27
    Diana, J., Beaudoin, L., Gautron, A. S. and Lehuen, A., NKT and tolerance. Methods Mol. Biol. 2011. 677: 193206.
  • 28
    Lisbonne, M., L'Helgoualc'h, A., Nauwelaers, G., Turlin, B., Lucas, C., Herbelin, A., Piquet-Pellorce, C. and Samson, M., Invariant natural killer T-cell-deficient mice display increased CCl4-induced hepatitis associated with CXCL1 over-expression and neutrophil infiltration. Eur. J. Immunol. 2011. 41: 17201732.